{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:55:33Z","timestamp":1793141733327,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.prp.2026.156400","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:37:02Z","timestamp":1770655022000},"page":"156400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["SIRT3 promotes oxaliplatin sensitivity in hepatocellular carcinoma by promoting ferroptosis through endoplasmic reticulum stress response"],"prefix":"10.1016","volume":"281","author":[{"given":"Yinkai","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuntao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prp.2026.156400_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2026.156400_bib2","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"issue":"5","key":"10.1016\/j.prp.2026.156400_bib3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00432-014-1806-0","article-title":"Management of hepatocellular carcinoma","volume":"141","author":"Fitzmorris","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156400_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5582\/ddt.2015.01047","article-title":"Systemic therapies for hepatocellular carcinoma","volume":"9","author":"Ge","year":"2015","journal-title":"Drug Discov. Ther."},{"issue":"12","key":"10.1016\/j.prp.2026.156400_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156400_bib6","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.prp.2026.156400_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.21037\/hbsn-22-469","article-title":"A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights","volume":"12","author":"Xie","year":"2023","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"7","key":"10.1016\/j.prp.2026.156400_bib8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","article-title":"Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.prp.2026.156400_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37613","article-title":"Ferroptosis-related oxaliplatin resistance in multiple cancers: Potential roles and therapeutic Implications","volume":"10","author":"Zhong","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.prp.2026.156400_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13030298","article-title":"Antioxidant systems as modulators of ferroptosis: focus on transcription factors","volume":"13","author":"Punziano","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.prp.2026.156400_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100936","article-title":"Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer","volume":"68","author":"Qu","year":"2023","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.prp.2026.156400_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.939605","article-title":"Silenced LINC01134 enhances oxaliplatin sensitivity by facilitating ferroptosis through GPX4 in hepatocarcinoma","volume":"12","author":"Kang","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib13","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41467-023-38753-6","article-title":"Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase","volume":"14","author":"Zhan","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.prp.2026.156400_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9070090","article-title":"SIRT3: oncogene and tumor suppressor in cancer","volume":"9","author":"Torrens-Mas","year":"2017","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s10020-023-00730-6","article-title":"Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH\/GPX4 pathway","volume":"29","author":"Wang","year":"2023","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156400_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41419-024-06558-0","article-title":"Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156400_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.prp.2026.156400_bib19","article-title":"Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response","volume":"118","author":"Lin","year":"2019","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.prp.2026.156400_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030695","article-title":"ER stress responses: an emerging modulator for innate immunity","volume":"9","author":"Di Conza","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.prp.2026.156400_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40425-016-0203-4","article-title":"Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer","volume":"5","author":"Cubillos-Ruiz","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13046-023-02656-7","article-title":"Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress","volume":"42","author":"Hu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ph11010002","article-title":"Roles of heat shock proteins in apoptosis, oxidative stress, human inflammatory diseases, and cancer","volume":"11","author":"Ikwegbue","year":"2017","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-021-02786-6","article-title":"GRP78 in lung cancer","volume":"19","author":"Xia","year":"2021","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.prp.2026.156400_bib25","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41401-022-01026-x","article-title":"Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting \u03b2-catenin K49 deacetylation","volume":"44","author":"Chen","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.prp.2026.156400_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.871560","article-title":"The double-edged sword of SIRT3 in cancer and its therapeutic applications","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.prp.2026.156400_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.14","article-title":"Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer","volume":"5","author":"Chen","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156400_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115573","article-title":"Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: mechanistical and pharmacological perspectives","volume":"212","author":"Ceballos","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.prp.2026.156400_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1995-7645(13)60112-1","article-title":"SIRT3 expression in hepatocellular carcinoma and its impact on proliferation and invasion of hepatoma cells","volume":"6","author":"Zhang","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"12","key":"10.1016\/j.prp.2026.156400_bib30","article-title":"Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2026.156400_bib32","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1002\/jcp.29727","article-title":"SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK\/mTOR pathway and promoting GPX4 levels","volume":"235","author":"Han","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.prp.2026.156400_bib33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41419-021-04134-4","article-title":"Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.prp.2026.156400_bib34","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.18632\/aging.101592","article-title":"Sirtuin 3 attenuates amyloid-\u03b2 induced neuronal hypometabolism","volume":"10","author":"Yin","year":"2018","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.prp.2026.156400_bib35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s12967-023-04246-9","article-title":"SIRT3 ameliorates diabetes-associated cognitive dysfunction via regulating mitochondria-associated ER membranes","volume":"21","author":"Chang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.prp.2026.156400_bib36","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.7150\/ijbs.85883","article-title":"Melatonin ameliorates hepatic ferroptosis in NAFLD by inhibiting ER stress via the MT2\/cAMP\/PKA\/IRE1 signaling pathway","volume":"19","author":"Guan","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.prp.2026.156400_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313010","article-title":"Epicatechin regulates endoplasmic reticulum stress and promotes ferroptosis in lung cancer cells via the PERK\/eIF2\u03b1\/ATF4 signaling pathway","volume":"19","author":"Lv","year":"2024","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.prp.2026.156400_bib38","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1002\/cam4.5605","article-title":"SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes","volume":"12","author":"Tong","year":"2023","journal-title":"Cancer Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:24:32Z","timestamp":1774121072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"alternative-id":["S0344033826000518"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156400","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIRT3 promotes oxaliplatin sensitivity in hepatocellular carcinoma by promoting ferroptosis through endoplasmic reticulum stress response","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156400"}}